1-3 of 3
Maria Sole Chimenti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics

Available to Purchase
Subject Area:
Dermatology , Immunology and Allergy
Maria Sole Chimenti, Miriam Teoli, Rosita Saraceno, Annunziata Dattola, Alessandra Ventura, Andrea Chiricozzi, Carlo Chiaramonte, Roberto Perricone, Sergio Chimenti
Journal: Dermatology
Dermatology (2014) 227 (4): 305–310.
https://doi.org/10.1159/000354263
Published Online: 19 November 2013
View articletitled, Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics
Open the PDF for Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics in another window
Journal Articles

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

Available to Purchase
Subject Area:
Dermatology , Immunology and Allergy
Maria Esposito, Alessandro Giunta, Annamaria Mazzotta, Arianna Zangrilli, Graziella Babino, Mauro Bavetta, Roberto Perricone, Sergio Chimenti, Maria Sole Chimenti
Journal: Dermatology
Dermatology (2013) 225 (4): 312–319.
https://doi.org/10.1159/000345623
Published Online: 28 December 2012
View articletitled, Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study
Open the PDF for Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study in another window
Journal Articles

Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy

Available to Purchase
Subject Area:
Dermatology , Immunology and Allergy
Antonio Costanzo, Marina Talamonti, Giulia Spallone, Elisabetta Botti, Maria Sole Chimenti, Marina Papoutsaki, Sergio Chimenti
Journal: Dermatology
Dermatology (2009) 218 (2): 146–150.
https://doi.org/10.1159/000168086
Published Online: 30 October 2008
View articletitled, Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy
Open the PDF for Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy in another window